Diane S. Aschenbrenner
Abstract
The gout medication febuxostat (Uloric) now carries a black box warning that it increases the risk of cardiovascular death in people with preexisting cardiovascular disease. NPs should prescribe febuxostat only if use of allopurinol fails to control gout or isn't tolerated.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The gout medication febuxostat (Uloric) now carries a black box warning that it increases the risk of cardiovascular death in people with preexisting cardiovascular disease. NPs should prescribe febuxostat only if use of allopurinol fails to control gout or isn't tolerated.
Key concepts: Febuxostat, Gout, Allopurinol, Medicine, Black box, Internal medicine, Intensive care medicine, Uric acid